Sangamo Therapeutics 10K 2015 Annual report | SGMO Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: absence, Adeno, Aldrich, alpha, ameliorate, Ashkenazi, attenuated, broader, CA, carefully, cDNA, cleared, clouding, concentrated, condensed, corneal, court, Cystic, decision, degradation, degrade, density, dermatan, deter, Dimension, disgorgement, doctor, dysfunction, elevate, enzymatic, ERT, expedite, explained, fat, formal, fundamental, galactosidase, globotriaosylceramide, glucocerebroside, growing, hearing, heparin, heritage, HSCT, hypertrophy, IDS, IDUA, Immunomodulatory, inclusion, inhibitor, interface, Jewish, kidney, knockout, land, landlord, left, lentiviral, lessor, leukopenia, Ligand, masked, mental, middle, milder, mortality, noncurrent, notable, Note, Oct, oral, organomegaly, owner, path, pediatric, plasmid, powerful, preconditioning, pronouncement, rail, randomly, rapid, refinement, retardation, Scheie, settlement, shell, simplification, singular, substrate, suitable, sulfate, swing, symptomology, thrombocytopenia, unsecured, unused, ventricular, Voyager, washout, weekly, white

Removed: alliance, antagonist, antagonize, assisted, aviremic, biallelic, biallelically, block, build, CHDI, collaborating, collected, correlation, Council, differentiated, disposed, emerge, engrafted, fall, fusion, Harvard, implemented, inflection, innovative, integrase, interfering, intractable, JDRF, JHU, knock, maraviroc, mission, monitored, mouse, multidisciplinary, mutual, neurodegenerative, observed, ocular, prescribed, protease, recommend, revolution, Selzentry, show, surgery, targeting, transcriptase, transmission, underwent

Sangamo Therapeutics (SGMO) 10-K2015 FY Annual report

Content analysis